Henry Jemil Esber Insider Profile
4 Followers
Henry Jemil Esber, Director at Seelos Therapeutics, holds 100.00K shares in Innovus Pharmaceuticals (Ticker: ~INNV), holds 13.00K shares in Nanomix (Ticker: NNMX), holds 609.22K shares in Seelos Therapeutics (Ticker: SEELQ). Most recently, Henry Jemil Esber Bought ― shares of Innovus Pharmaceuticals on Nov 27, 2017 for an estimated value of $9.00K.
Henry Jemil Esber's Trading History
You May Also Like
Henry Jemil Esber insider profile FAQ
What is the percentage of profitable transactions made by Henry Jemil Esber?
The percentage of profitable transactions made by Henry Jemil Esber is 50%.
What is the average return per transaction made by Henry Jemil Esber?
The average return per transaction made by Henry Jemil Esber is 5.00%.
What stocks does Henry Jemil Esber hold?
Henry Jemil Esber holds: SEELQ, NNMX, ~INNV, GALT stocks.
What was Henry Jemil Esber’s latest transaction?
Henry Jemil Esber’s latest transaction was an Informative Buy of $9.00K.
What was Henry Jemil Esber's most profitable transaction?
Henry Jemil Esber’s most profitable transaction was an Informative Buy of ~INNV stock on November 27, 2017. The return on the trade was 29.40%.
What is Henry Jemil Esber's role in Seelos Therapeutics?
Henry Jemil Esber's role in Seelos Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
